# Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

Source: https://onco.cc/trials/nct00722228/  
OnCo record `nct00722228` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in colorectal cancer, run by Hadassah Medical Organization, now recruiting.

## Summary

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors is a phase 1/2, interventional study registered as NCT00722228 by Hadassah Medical Organization, with a registry enrolment figure of 50 participants, started 2008-07 and due to reach its primary completion in 2025-03. Interventions recorded: Autologous or Allogeneic tumor cells. Conditions listed: Colorectal Cancer; Ovarian Cancer; Gastric Cancer; Breast Cancer; Lung Cancer; Kidney Cancer; Melanoma. Colorectal eligibility wording from the registry: "* One of the following metastatic cancers: Melanoma, breast, ovary, colorectal, gastric, lung or kidney". Sites: Israel. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT00722228
- Phase: 1/2
- Setting: Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Sponsor: Hadassah Medical Organization
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT00722228: https://clinicaltrials.gov/study/NCT00722228

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Off-the-shelf cancer vaccines](https://onco.cc/technologies/shared-antigen-vaccine/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct00722228.json